Gabapentin Market Analysis

Distribution Channel (Retail Pharmacy, Hospital Pharmacy, Online Pharmacy)

The hospital pharmacy segment is anticipated to account for 45% share of the global gabapentin market during the projected period. The hospital pharmacies also have exposure to patients' medical records which leads to high accuracy in medication provision. Besides, the growing demand for advanced healthcare infrastructure, especially in developing countries along with high investment in new technologies and the healthcare sector is expected to influence the segment growth in the upcoming times. Given the risk of misuse, most medicines are provided by hospitals or the healthcare industry. According to a US national survey, 6.6% of persons reported misusing gabapentin at some point in their lives, with therapeutic and non-therapeutic uses split fairly evenly.

Dosage Form (Tablet, Capsule, Oral Solution)

The capsule segment in the gabapentin market is predicted to witness the largest revenue of 50 % by the end of 2035. The gabapentin medication is available in the market in various forms but the most popular and demanding form is the capsule form, owing to its easy availability, ease of administration, and correct dosing. One of the significant advantages of capsules is that they are easy to swallow which means old people or kids can take them easily and most doctors prescribe capsules over other forms owing to their huge properties.

Our in-depth analysis of the global gabapentin market includes the following segments:

Dosage Form	Tablet Capsule Oral Solution
Type	Generic Branded
Application	Neuropathic Pain Epilepsy Restless Legs Syndrome Others
Distribution Channel	Retail Pharmacy Hospital Pharmacy Online Pharmacy

Frequently Asked Questions (FAQ)

The rising prevalence of neuropathic pain and the increasing availability of generic versions are some of the major factors anticipated to drive the growth of the gabapentin market.

The market is anticipated to attain a CAGR of ~5% over the forecast period, i.e., 2023 â€“ 2035.

The major players in the market are Ascend Laboratories, LLC Apotex Inc., Teva Pharmaceutical Industries Ltd., Aurobindo Pharma., Amneal Pharmaceuticals LLC., Cipla USA, Inc., BP Pharmaceuticals Laboratories Company, Assertio Holdings, Inc., Arbor Pharmaceuticals, Inc., and others.

The hospital pharmacy segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.

The market in North America is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.

Gabapentin Market Analysis